Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2012/03/002471
CTRI/2012/03/002471
Completed
未知

Studies on Antiviral Therapy that limits the Emergence of HBV Resistance in HIV/HBV Co-infection

Calcutta School of Tropical Medicine0 sites68 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- HIV/HBV co infected ART naive and experienced patients.

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- HIV/HBV co infected ART naive and experienced patients.
Sponsor
Calcutta School of Tropical Medicine
Enrollment
68
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Calcutta School of Tropical Medicine

Eligibility Criteria

Inclusion Criteria

  • •Study â?? I
  • •1\)Patients above 14 years with documented HIV infection as per NACO guideline along with chronic Hepatitis B
  • •2\)HIV/HBV co\-infection of unknown duration with indication of starting ART
  • •3\)Willing to give written informed consent (by self or by guardian in case of \< 18 years of age)
  • •Study â?? II
  • •1\.HBV mono\- infected chronic hepatitis patients on 3TC treatment for one year or more.
  • •2\.HIV positive HBV co\-infected patients on lamivudine containing ART for at least 1 year
  • •Study â?? I \& II
  • •1\) Blood Parameters
  • •a.Serum creatinine \< 1\.5 mg/dl

Exclusion Criteria

  • •1\. Active alcohol abuse over last 6 months or \> 40 gm/week and any substance use that physician feels can affect the adherence
  • •2\. Presence of associated co\-infection with HCV, HAV or HEV
  • •3\. Associated life\-threatening disease
  • •4\. Presence of any malignancy
  • •5\.Elevated serum creatinine level \> 1\.5 mg/dl documented at least twice at one week interval in the last three months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Investigation of antiviral treatment for symptomatic congenital cytomegalovirus infectioCongenital cytomegalovirus infection
JPRN-UMIN000019464Department of Pediatrics, Nagoya University Graduate School of Medicine20
Active, not recruiting
Phase 4
Study to compare the effect of different antiviral medicines in COVID-19 infected sick childreHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/10/028234Dept of Pediatrics Medical College Kolkata
Recruiting
Not Applicable
Antiviral therapy with direct acting anti-virals in hepatitis C patients.Chronic hepatitis C
JPRN-UMIN000016288Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine500
Completed
Not Applicable
Resarch of the effect of antiviral drugs on the suppression of COVID-19 persistent symptomsCOVID-19
JPRN-UMIN000048380agasaki University382
Completed
Not Applicable
A Phase III Study Comparing the Antiviral Efficacy and Safety of BMS-232632 with Efavirenz; Each in Combination with Fixed Dose Zidovudine-Lamivudine-B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseasesHuman immunodeficiency virus [HIV] disease resulting in other specified diseasesB22
PER-076-00BRISTOL MYERS SQUIBB PERU S.A.,